DE3705074A1 - Temazepamzusammensetzung - Google Patents
TemazepamzusammensetzungInfo
- Publication number
- DE3705074A1 DE3705074A1 DE19873705074 DE3705074A DE3705074A1 DE 3705074 A1 DE3705074 A1 DE 3705074A1 DE 19873705074 DE19873705074 DE 19873705074 DE 3705074 A DE3705074 A DE 3705074A DE 3705074 A1 DE3705074 A1 DE 3705074A1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- composition according
- alcohol
- combined
- temazepam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims description 51
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 title claims description 25
- 229960003188 temazepam Drugs 0.000 title claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000012928 buffer substance Substances 0.000 claims description 8
- 235000019501 Lemon oil Nutrition 0.000 claims description 7
- 239000010501 lemon oil Substances 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 229930002875 chlorophyll Natural products 0.000 claims description 5
- 235000019804 chlorophyll Nutrition 0.000 claims description 5
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical group C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims description 4
- 239000001488 sodium phosphate Substances 0.000 claims description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 3
- 235000019477 peppermint oil Nutrition 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 239000006172 buffering agent Substances 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- WPNMLCMTDCANOZ-UHFFFAOYSA-N [5-chloro-2-(methylamino)phenyl]-phenylmethanone Chemical compound CNC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 WPNMLCMTDCANOZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 229940069328 povidone Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000014766 Mentha X piperi var citrata Nutrition 0.000 description 1
- 235000007421 Mentha citrata Nutrition 0.000 description 1
- 235000008660 Mentha x piperita subsp citrata Nutrition 0.000 description 1
- 240000003637 Monarda citriodora Species 0.000 description 1
- 235000002431 Monarda citriodora Nutrition 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8602664A GB2185887B (en) | 1987-02-18 | 1986-02-04 | Temazepam composition |
| DE19873705074 DE3705074A1 (de) | 1987-02-18 | 1987-02-18 | Temazepamzusammensetzung |
| CH62387A CH671881A5 (enrdf_load_stackoverflow) | 1987-02-18 | 1987-02-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873705074 DE3705074A1 (de) | 1987-02-18 | 1987-02-18 | Temazepamzusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3705074A1 true DE3705074A1 (de) | 1988-09-01 |
Family
ID=6321211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19873705074 Withdrawn DE3705074A1 (de) | 1987-02-18 | 1987-02-18 | Temazepamzusammensetzung |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH671881A5 (enrdf_load_stackoverflow) |
| DE (1) | DE3705074A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2185887B (enrdf_load_stackoverflow) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8926612D0 (en) * | 1989-11-24 | 1990-01-17 | Erba Farmitalia | Pharmaceutical compositions |
| US5141961A (en) * | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
| US5431916A (en) * | 1993-04-29 | 1995-07-11 | The Procter & Gamble Company | Pharmaceutical compositions and process of manufacture thereof |
| US5484606A (en) * | 1994-01-24 | 1996-01-16 | The Procter & Gamble Company | Process for reducing the precipitation of difficulty soluble pharmaceutical actives |
| KR100746753B1 (ko) * | 1998-08-28 | 2007-08-06 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 고미 등을 경감한 의약조성물 |
| EP1064937A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1345510A (en) * | 1972-01-21 | 1974-01-30 | American Home Prod | Parenteral benzodiazepine compositions |
| DE3221402A1 (de) * | 1982-06-05 | 1983-12-08 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen |
-
1986
- 1986-02-04 GB GB8602664A patent/GB2185887B/en not_active Expired
-
1987
- 1987-02-18 DE DE19873705074 patent/DE3705074A1/de not_active Withdrawn
- 1987-02-19 CH CH62387A patent/CH671881A5/de not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1345510A (en) * | 1972-01-21 | 1974-01-30 | American Home Prod | Parenteral benzodiazepine compositions |
| DE3221402A1 (de) * | 1982-06-05 | 1983-12-08 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen |
Non-Patent Citations (1)
| Title |
|---|
| GSTIRNER, F.: Einführung in die Verfahrens- technik der Arzneiformung, 5. Auflage, 1973, S. 271-274 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2185887B (en) | 1989-12-06 |
| GB2185887A (en) | 1987-08-05 |
| GB8602664D0 (en) | 1986-03-12 |
| CH671881A5 (enrdf_load_stackoverflow) | 1989-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0182007B1 (de) | Nifedipin enthaltende Darreichungsform und Verfahren zu ihrer Herstellung | |
| AT402692B (de) | Antigeschwulstmittel und verfahren zu ihrer herstellung | |
| DE3922650C2 (enrdf_load_stackoverflow) | ||
| DE2654184A1 (de) | Verfahren zur herstellung von getraenken bitterer geschmacksrichtung | |
| DE2708152B2 (de) | Pharmazeutisches Trägermaterial für die örtliche Aufbringung auf Schleimhäuten | |
| EP0817610B1 (de) | Steriles tropfbares ophthalmisches gelpräparat und verfahren zu dessen herstellung | |
| EP1431385A1 (de) | Xanthohumol-haltiges Getränk | |
| DE69620691T2 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
| DE68906765T2 (de) | Zusammensetzung mit einem extrakt,das durch extraktion mit einem wasserhaltigen organischen loesungsmittel erhalten wurde und verfahren zu seiner herstellung. | |
| EP0240484A1 (de) | Pharmazeutische Zubereitung sowie Verfahren zur Herstellung derselben | |
| DE2601489C2 (enrdf_load_stackoverflow) | ||
| DE60218738T2 (de) | Augentropfen | |
| DE3705074A1 (de) | Temazepamzusammensetzung | |
| EP0461505B1 (de) | Nitroglycerin-Spray | |
| DE19509856C2 (de) | Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen | |
| DE1617557A1 (de) | Stabile Oryzanolloesung und Verfahren zur Herstellung derselben | |
| DE69912978T2 (de) | Oral anzuwendendes sertralinhaltiges konzentrat | |
| DE60101979T2 (de) | Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel | |
| DE19818802A1 (de) | Stabile Mitoxantron-Lösungen | |
| DE2416216A1 (de) | Pharmazeutische zusammensetzung, verfahren zu deren herstellung und verwendung eines vehiculums dafuer | |
| DE1617638A1 (de) | Tablettenbindemittel | |
| DE19527140A1 (de) | Sprühbare Lösungen mit blutdrucksenkender Wirkung und Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| DE1207374B (de) | Verfahren zur Erhoehung der Bestaendigkeit von fester 1-Ascorbinsaeure | |
| DE3208505A1 (de) | Mittel mit einem gehalt an einem lyophilisierten penicillinderivat | |
| DE3237284C2 (enrdf_load_stackoverflow) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8127 | New person/name/address of the applicant |
Owner name: FARMITALIA CARLO ERBA S.R.L., MAILAND/MILANO, IT |
|
| 8127 | New person/name/address of the applicant |
Owner name: PHARMACIA & UPJOHN S.P.A., MAILAND/MILANO, IT |
|
| 8130 | Withdrawal |